<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/" xmlns:turbo="http://turbo.yandex.ru" version="2.0">
<channel>
<title>Dr. Alireza Arefzadeh</title>
<link>https://drarefzadeh.com/</link>
<language>fa</language>
<description>Dr. Alireza Arefzadeh</description>
<generator>DataLife Engine</generator><item>
<title>Artificial Intelligence and Diabetes</title>
<guid isPermaLink="true">https://drarefzadeh.com/26-Artificial-Intelligence-and-Diabetes.html</guid>
<link>https://drarefzadeh.com/26-Artificial-Intelligence-and-Diabetes.html</link>
<description><![CDATA[<p style="text-align:center;"> </p>
<p style="text-align:center;"><span style="font-size:18pt;"><strong>Artificial Intelligence and Diabetes</strong></span></p>
<p style="text-align:center;"> </p>
<p style="text-align:left;">Diabetes mellitus is recognized as one of the most significant chronic metabolic disorders and has emerged as a major global health challenge over recent decades. The continuous rise in the prevalence of this disease has resulted in millions of individuals worldwide experiencing its consequences, while healthcare systems face substantial financial and operational burdens associated with its management. Current projections suggest that, if existing trends persist, the global population living with diabetes may reach approximately 700 million by 2045. Beyond the growing number of affected individuals, inadequate glycemic control is a major contributing factor to the development of severe complications, including diabetic eye disease, impaired kidney function, neurological damage, cardiovascular disorders, and diabetic foot ulcers. These complications not only substantially diminish patients’ quality of life but also impose considerable costs on healthcare infrastructures.</p>
<p style="text-align:left;"> </p>
<p style="text-align:left;">Given this growing burden, the integration of advanced technologies, particularly artificial intelligence (AI), has attracted increasing attention as a promising strategy for improving diabetes management. This study aims to explore the potential applications and capabilities of AI-based approaches in enhancing glycemic control among individuals with diabetes. Through a comprehensive perspective, it examines the contribution of AI technologies to early disease detection, prediction of glucose fluctuations, optimization of therapeutic interventions, and reduction of the risk of both acute and long-term diabetes-related complications.</p>
<p style="text-align:left;"> </p>
<p style="text-align:left;">Evidence from recent research indicates that artificial intelligence techniques, including machine learning algorithms and artificial neural networks, possess considerable potential for analyzing complex glucose-related patterns due to their ability to process large-scale medical datasets and identify relationships that may not be easily detectable through conventional approaches. These computational models can anticipate episodes of severe hyperglycemia or hypoglycemia before they occur, support automated insulin regulation in artificial pancreas systems, and generate individualized treatment and self-management recommendations based on patient-specific characteristics and clinical data.</p>
<p style="text-align:left;"> </p>
<p style="text-align:left;">Furthermore, numerous investigations have demonstrated that AI-enabled continuous glucose monitoring systems, intelligent mobile health applications, and digital healthcare assistants can positively influence diabetes outcomes. By facilitating more accurate disease monitoring and personalized decision-making, these technologies have been associated with improvements in key clinical indicators, including reductions in glycated hemoglobin (HbA1c) levels, increased time spent within the target glucose range, and decreased frequency of hypoglycemic and hyperglycemic events. Consequently, AI-driven solutions may enhance the effectiveness of current diabetes care strategies and contribute to more proactive disease management.</p>
<p style="text-align:left;"> </p>
<p style="text-align:left;">Despite these promising advantages, the widespread adoption of artificial intelligence in diabetes care remains subject to several important challenges. These include limitations related to the quality, consistency, and standardization of medical data; concerns regarding patient privacy and data security; the need for greater transparency and interpretability of AI models; and difficulties associated with integrating these technologies into existing healthcare infrastructures. Therefore, further clinical research, along with the development of comprehensive regulatory frameworks and practical implementation guidelines, is essential to ensure the safe, effective, and sustainable incorporation of artificial intelligence into diabetes management. </p>
<p style="text-align:left;"> </p>
<p style="text-align:left;">More read: click on the link</p>
<p style="text-align:left;"> </p>
<p style="text-align:left;"> </p>
<p style="text-align:left;"> </p>
<p style="text-align:center;"><span style="font-size:24pt;"><strong><a title="Article Alireza Arefzadeh" href="https://civilica.com/doc/2563429/" target="_blank" rel="noopener external noreferrer">The link</a></strong></span></p>]]></description>
<category><![CDATA[Artificial Intelligence and Diabetes]]></category>
<dc:creator>site-admin</dc:creator>
<pubDate>Tue, 07 Jul 2026 21:26:44 +0330</pubDate>
</item><item>
<title>A Review of Thyroid Dysfunction due to COVID-19</title>
<guid isPermaLink="true">https://drarefzadeh.com/25-A-Review-of-Thyroid-Dysfunction-due-to-COVID-19.html</guid>
<link>https://drarefzadeh.com/25-A-Review-of-Thyroid-Dysfunction-due-to-COVID-19.html</link>
<description><![CDATA[<h1 class="heading-title" style="text-align: center;">&nbsp;</h1>
<h1 class="heading-title" style="text-align: center;"><span style="font-size: 18pt;"><strong>A Review of Thyroid Dysfunction due to COVID-19</strong></span></h1>
<p style="text-align: center;"><span style="font-size: 14pt;"><strong>&nbsp;</strong></span></p>
<p style="text-align: center;"><span style="font-size: 14pt;"><strong>Please click to this link:&nbsp;</strong></span></p>
<p style="text-align: center;"><span style="font-size: 14pt;"><strong>&nbsp;</strong></span></p>
<p style="text-align: center;"><span style="font-size: 14pt;"><strong>&nbsp;</strong></span></p>
<p style="text-align: center;"><span style="font-size: 14pt;"><strong>&nbsp;</strong></span></p>
<p style="text-align: center;"><span style="font-size: 14pt;"><strong><a href="https://pubmed.ncbi.nlm.nih.gov/37069724/" target="_blank">&lt;Article link&gt;</a><br /></strong></span></p>
<p style="text-align: center;"><span style="font-size: 14pt;"><strong>&nbsp;</strong></span></p>
<p style="text-align: center;"><span style="font-size: 14pt;"><strong>&nbsp;</strong></span></p>
<p style="text-align: center;"><span style="font-size: 14pt;"><strong>&nbsp;</strong></span></p>
<header id="heading" class="heading">
<div class="full-view" id="full-view-heading">
<h1 class="heading-title" style="text-align: left;"><span style="font-size: 14pt;"><strong>&nbsp;</strong></span></h1>
<h1 class="heading-title" style="text-align: left;"><span style="font-size: 14pt;">A Review of Thyroid Dysfunction due to COVID-19</span></h1>
<p style="text-align: left;"><span style="font-size: 14pt;">&nbsp;</span></p>
<div class="inline-authors" style="text-align: left;">
<div class="authors">
<div class="authors-list"><span style="font-size: 14pt;"><strong><span class="authors-list-item ">Alireza Arefzadeh<span class="affiliation-links"><span class="author-sup-separator">&nbsp;</span>1</span></span></strong></span></div>
</div>
</div>
<div class="short-article-details" style="text-align: left;"></div>
<div class="short-article-details" style="text-align: left;"></div>
<div class="short-article-details" style="text-align: left;"></div>
<div class="short-article-details" style="text-align: left;"><span style="font-size: 14pt;"><strong>Abstract</strong></span></div>
<div class="short-article-details" style="text-align: left;"></div>
<div class="short-article-details" style="text-align: left;"></div>
<div class="short-article-details" style="text-align: left;"></div>
</div>
</header>
<div class="abstract" id="abstract">
<div class="abstract-content selected" style="text-align: left;" id="eng-abstract">
<p><span style="font-size: 14pt;"><strong>Coronavirus disease 2019 (COVID-19) affects thyroid function.</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>These changes are due to the direct impact of the virus on thyroid</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>cells via angiotensin-converting&ndash;enzyme 2 (ACE2) receptors,</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>inflammatory reaction, apoptosis in thyroid follicular cells,</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>suppression of hypothalamus-pituitary-thyroid axis,</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>an increase in activity of adrenocortical axis,</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>and excess cortisol release due to cytokine storm</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>Euthyroid sick syndrome (ESS), thyroiditis, clinical and subclinical</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>hypothyroidism, central hypothyroidism, exacerbation of</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>underlying autoimmune thyroid disease, and clinical and</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>subclinical hyperthyroidism can be associated with coronavirus.</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>Adjuvants in coronavirus vaccines induce autoimmune/inflammatory syndrome</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>known as vaccine adjuvants (ASIA) syndrome.</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>Thyroiditis and Graves&rsquo; disease have been reported</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>to be associated with ASIA syndrome after some coronavirus</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>vaccinations. Some coronavirus medications, such as hydroxychloroquine,</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>monoclonal antibodies, lopinavir/ritonavir, remdesivir, naproxen,</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>anticoagulants, and glucocorticoids can also affect thyroid tests,</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>and correct diagnosis of thyroid disorders will be more difficult.</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>Conclusion:&nbsp;Changes in thyroid tests may be one of the most</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>important manifestations of COVID-19.</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>These changes can be confusing for clinicians and can lead to</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>inappropriate diagnoses and decisions.</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>Prospective studies should be conducted in the future to increase</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>epidemiological and clinical data and optimize the management</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;"><strong>of thyroid dysfunctions in patients with COVID-19.</strong></span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
</div>
<p style="text-align: left;"><span style="font-size: 14pt;"><strong>Keywords:&nbsp;Coronavirus disease 2019; severe acute</strong></span></p>
<p style="text-align: left;"><span style="font-size: 14pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 14pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 14pt;"><strong>respiratory syndrome coronavirus 2; thyroid hormone;</strong></span></p>
<p style="text-align: left;"><span style="font-size: 14pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 14pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 14pt;"><strong>thyroiditis; autoimmune disease; hyperthyroidism;</strong></span></p>
<p style="text-align: left;"><span style="font-size: 14pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 14pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 14pt;"><strong>hypothyroidism; euthyroid sick syndrome; pandemic;</strong></span></p>
<p style="text-align: left;"><span style="font-size: 14pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 14pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 14pt;"><strong>subclinical thyroiditis; painless thyrotoxicosis; thyroid&nbsp;dysfunction; thyrotoxicosis.</strong></span></p>
<p style="text-align: left;"><span style="font-size: 14pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 14pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 14pt;"><strong>The author of the article:</strong></span></p>
<p style="text-align: left;"><span style="font-size: 14pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 14pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 14pt;"><strong>Dr. Alireza Arefzadeh,</strong></span></p>
<p style="text-align: left;"><span style="font-size: 14pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 14pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 14pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 14pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 14pt;"><strong>Endocrinologist</strong></span></p>
<p style="text-align: left;"><span style="font-size: 14pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 14pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 14pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 14pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 8pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 8pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 8pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 8pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 8pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 8pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 8pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 8pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 8pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 8pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 8pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 8pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 8pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 8pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 8pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 8pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 8pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 8pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 8pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 8pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 8pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 8pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p><span style="font-size: 14pt;">&nbsp;</span></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>درمان چاقی شکم با آر اف درمان چاقی شکم چاقی شکم آر اف شکم آر اف کویتیشن اولتراسوند فوق تخصص غدد در تهران فوق تخصص غدد تهران بهترین فوق تخصص غدد تهران شمال جنوب شرق غرب بهترین فوق تخصص غدد در تهران بهترین فوق تخصص غدد تهران بهترین فوق تخصص غدد در شمال تهران بهترین فوق تخصص غدد در غرب تهران دکتر غدد در تهران بهترین دکتر متخصص غدد در تهران لیست پزشکان فوق تخصص غدد در تهران بهترین دکتر فوق تخصص غدد در تهران بهترین متخصص غدد در تهران متخصص غدد تهران بهترین متخصص غدد تهران متخصص غدد در تهران متخصص تیروئید تهران متخصص دیابت تهران متخصص تیروئید متخصص دیابت متخصص دیابت در تهران آدرس دکتر متخصص غدد در تهران آدرس دکتر فوق تخصص غدد در تهران متخصص تیروئید در تهران دکتر متخصص تیروئید در تهران بهترین فوق تخصص غدد تهران شمال جنوب شرق غرب متخصص داخلی دیابت تیروئید چاقی رشد بلوغ نازایی متخصص غدد خوب تهران دکتر متخصص غدد خوب در تهران دکتر متخصص دیابت در تهران دکتر متخصص تیروئید در تهران کلینیک فوق تخصصی غدد دکتر فوق تخصص غدد تیروئید کلینیک فوق تخصصی تیروئید دکتر متخصص غدد تیروئید دکتر متخصص غدد دیابت دکتر متخصص دیابت دکتر فوق تخصص غدد دیابت متخصص غدد تیروئید فوق تخصص غدد دیابت بهترین دکتر فوق تخصص غدد در تهران بهترین دکتر فوق تخصص تیروئید در تهران بهترین دکتر فوق تخصص دیابت در تهران بهترین دکتر متخصص رشد در تهران بهترین دکتر فوق تخصص رشد در تهران کلینیک فوق تخصصی دیابت کلینیک فوق تخصصی دیابت در تهران معرفی دکتر فوق تخصص غدد در تهران دکتر غدد خوب در تهران دکتر خوب غدد در تهران دکتر علیرضا عارف زاده فوق تخصص غدد دکتر علیرضا عارف زاده دکتر عارف زاده فوق تخصص غدد Dr alireza arefzadeh بهترین فوق تخصص غدد تهران شمال متخصص غدد شرق غرب جنوب فوق تخصص غدد بهترین فوق تخصص غدد بهترین فوق تخصص غدد تهران بهترین فوق تخصص غدد در تهران فوق تخصص غدد در تهران فوق تخصص غدد تهران فوق تخصص خوب غدد تهران فوق تخصص خوب غدد شمال تهران بهترین فوق تخصص غدد شرق تهران بهترین شمال تهران متخصص غدد بهترین متخصص غدد جنوب تهران بهترین متخصص غدد غرب تهران بهترین فوق تخصص غدد شمال تهران بهترین فوق تخصص غدد در شمال تهران متخصص غدد متخصص غدد تهران بهترین متخصص غدد تهران متخصص غدد در شمال تهران بهترین متخصص غدد در تهران فوق تخصص غدد در شمال تهران بهترین فوق تخصص غدد غرب تهران بهترین فوق تخصص غدد در غرب تهران بهترین فوق تخصص متخصص غدد شمال تهران دکتر غدد خوب در تهران دکتر خوب غدد در تهران دکتر علیرضا عارف زاده فوق تخصص غدد دکتر علیرضا عارف زاده Dr alireza arefzadeh</p>
<div class="clr"></div>
<p class="basetags"><em>ا</em></p>
</div>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>]]></description>
<category><![CDATA[A Review of Thyroid Dysfunction due to COVID-19]]></category>
<dc:creator>site-admin</dc:creator>
<pubDate>Fri, 01 Sep 2023 20:50:19 +0330</pubDate>
</item><item>
<title>Association of the Thyroid Nodules With FNA</title>
<guid isPermaLink="true">https://drarefzadeh.com/24-Association-of-the-Thyroid-Nodules-With-FNA.html</guid>
<link>https://drarefzadeh.com/24-Association-of-the-Thyroid-Nodules-With-FNA.html</link>
<description><![CDATA[<p style="text-align: center;">&nbsp;</p>
<p style="text-align: center;"><img title="" src="http://drarefzadeh.com/uploads/posts/2023-07/1689265957_fna.jpg" alt="" /></p>
<p style="text-align: center;">&nbsp;</p>
<p style="text-align: center;">&nbsp;</p>
<p style="text-align: center;">&nbsp;</p>
<p style="text-align: center;"><span style="font-size: 24pt;"><strong>Association of the Thyroid Nodules With FNA</strong></span></p>
<p style="text-align: center;">&nbsp;</p>
<p style="text-align: center;">&nbsp;</p>
<p style="text-align: center;">&nbsp;</p>
<p style="text-align: left;"><span style="font-size: 24pt;"><strong>&nbsp;</strong></span></p>
<p style="text-align: center;">&nbsp;</p>
<p style="text-align: center;">&nbsp;</p>
<p style="text-align: center;"><span style="font-size: 24pt;"><strong>Please cick this link in below:</strong></span></p>
<p style="text-align: center;">&nbsp;</p>
<p style="text-align: center;"><span style="font-size: 14pt;"><strong> &nbsp; &nbsp;&nbsp;</strong></span></p>
<p style="text-align: center;"><span style="font-size: 24pt;"><strong>&lt;<a href="https://publish.kne-publishing.com/index.php/ACTA/article/view/12738" target="_blank"><span style="text-decoration: underline;">Article Link</span></a>&gt;</strong></span></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<h3 class="label" style="text-align: left;"><strong><span style="font-size: 14pt;">Abstract</span></strong></h3>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">Thyroid nodules are a common finding in clinical practice. </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">Although ultrasonography is an accepted method for evaluating</span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;"> these nodules, Fine Needle Aspiration (FNA) is the procedure of </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">choice for assessing the risk of malignancy. This study aims to determine </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">the association between sonographic features of thyroid nodules based on</span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;"> Thyroid Imaging Reporting and Data System classification and the cytology results.</span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;"> In this prospective cohort study, 147 patients from Tehran Medical Imaging Center</span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;"> who had thyroid nodules underwent ultrasonography-guided FNA,</span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;"> and their sonographic features were recorded. </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">The pathologic findings were also obtained according to the Bethesda system. </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">inally, the association between sonographic features and cytological results was</span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;"> analyzed. </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">Eighteen (12.3%) nodules were malignant, and 129 nodules (87.7%) were benign. The</span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;"> association of TIRADS categories with the risk of malignancy is as follows: </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">TIRADS 1 (n=0, 0%), TIRADS 2 (n=10, 16.9%), TIRADS 3 (n=6, 10.5%), TIRADS 4 (n=2, 16.7%), and TIRADS 5 (n=0, 0%). </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">The bloody lamellae of thyroid nodules were significantly correlated with</span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;"> the risk of malignancy (<em>P</em>&lt;0.05). </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">However, there was no statistically significant association between</span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;"> the risk of malignancy and gender (<em>P</em>=0.47), calcification (<em>P</em>=0.9), </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">firmness (<em>P</em>=0.19), halo sign (<em>P</em>=0.95), location of nodules (<em>P</em>=0.35), </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">and nodules' echogenicity (<em>P</em>=0.058). </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">Although there are trusted classifications such as TIRADS for </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">categorizing thyroid nodules, there is still uncertainty in utilizing them, </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">especially in the management of nodules classified as TIRADS 2, </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">.</span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">in which various sonographic features are shared between benign and malignant nodules.</span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">Although, based on the ACR guideline, we do not perform FNA </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">with all nodules that have TIRADS 2, regardless of the size or other characteristics </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">of the nodule, </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">there is a possibility that some of these nodules will be malignant in the future,</span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;"> so it is considered. </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">It seems that the guideline should be revised regarding TIRADS 2, </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">and under certain circumstances, </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">these types of nodules should also be sampled under FNA ultrasound guidance</span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;"> with some criteria such as size or other features, </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">because there may be problems in the future, </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">contrary to what the guideline currently recommends, </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">that sampling TIRADS 2 is not required. </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">&nbsp;</span></strong><strong><span style="font-size: 14pt;">be created and find out that some of these types of nodules are&nbsp;</span></strong><strong><span style="font-size: 14pt;">malignant&nbsp;</span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">Although currently, the ACR guideline does not recommend performing </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">thyroid nodule FNA with TIRADS 2 </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">unless the patient has a positive family history of thyroid cancer, </span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 14pt;">. especially if family history is the MTC type or MEN.</span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 12pt;">Author and compiler:</span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><strong><span style="font-size: 12pt;"> Dr. Alireza Arefzadeh</span></strong></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><span style="font-size: 8pt;">endocrinology and metabolism specialist in Tehran</span></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><span style="font-size: 8pt;">specialist in endocrine diseases in Tehran</span></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><span style="font-size: 8pt;">the best endocrinologist in Tehran</span></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><span style="font-size: 8pt;">the best endocrinologist in Tehran</span></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><span style="font-size: 8pt;">the best subspecialist in Iran</span></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><span style="font-size: 8pt;">the best endocrinologist in Iran</span></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><span style="font-size: 8pt;">the best endocrinologist in Tehran</span></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><span style="font-size: 8pt;">the best endocrinologist in Iran</span></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><span style="font-size: 8pt;">the best specialist&nbsp;Thyroid in Tehran</span></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><span style="font-size: 8pt;"> FNA</span></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><span style="font-size: 8pt;"> thyroid ultrasound</span></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>]]></description>
<category><![CDATA[Association of the Thyroid Nodules With FNA]]></category>
<dc:creator>site-admin</dc:creator>
<pubDate>Thu, 13 Jul 2023 21:13:44 +0330</pubDate>
</item><item>
<title>Evaluation of Ethanol Injection, Radiofrequency Ablation, and Levothyroxine Therapy in the Management of Benign Thyroid Nodules</title>
<guid isPermaLink="true">https://drarefzadeh.com/23-Evaluation-of-Ethanol-Injection,-Radiofrequency-Ablation,-and-Levothyroxine-Therapy-in-the-Management-of-Benign-Thyroid-Nodules.html</guid>
<link>https://drarefzadeh.com/23-Evaluation-of-Ethanol-Injection,-Radiofrequency-Ablation,-and-Levothyroxine-Therapy-in-the-Management-of-Benign-Thyroid-Nodules.html</link>
<description><![CDATA[<h1 class="black">Evaluation of Ethanol Injection, Radiofrequency Ablation, and Levothyroxine Therapy in the Management of Benign Thyroid Nodules</h1>
<p>&nbsp;</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp;&nbsp;&nbsp; <a href="https://brieflands.com/articles/iranjradiol-114004.html" target="_blank"><span style="font-size: 18pt;"><strong>&lt;Click here&gt; </strong></span></a></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<h3 id="subject-1" class="mb side divider active subject title">Abstract</h3>
<div class="abstract-block">
<article>
<div class="mb content text-indent">
<h4 class="font-main d-inline font-weight-bold">Background:</h4>
Thyroid nodules are common clinical findings. Although there are various accepted treatments for benign thyroid nodules, such as surgery and thermal treatment, there are some alternative methods for the management of these patients at lower costs with minimal complications.</div>
</article>
<article>
<div class="mb content text-indent">
<h4 class="font-main d-inline font-weight-bold">Objectives:</h4>
This study aimed to compare volume reduction in radiofrequency (RF) ablation and single-session ethanol ablation (EA) and to investigate the effects of levothyroxine therapy (LT4) on benign thyroid nodules.</div>
</article>
<article>
<div class="mb content text-indent">
<h4 class="font-main d-inline font-weight-bold">Patients and Methods:</h4>
In this clinical trial, 91 patients with benign thyroid nodules, presenting to different medical centers in Tehran, Iran, from December 6, 2018, to December 6, 2019, were included. Patients who met the inclusion criteria were selected and randomly allocated into three groups: group 1, a single session of RF ablation (n = 31); group 2, a single session of ethanol injection (n = 30); and group 3, a six-month LT4 treatment (n = 30). Thyroid tests, including thyroid stimulating hormone (TSH), thyroxine (T4), triiodothyronine (T3), anti-thyroid peroxidase (anti-TPO), T3 resin uptake (T3RU), and serum calcitonin level, were recorded at baseline and within one-, three-, and six-month intervals. The nodule volume was also assessed using sonography at baseline and in the follow-ups.</div>
</article>
<article>
<div class="mb content text-indent">
<h4 class="font-main d-inline font-weight-bold">Results:</h4>
The mean volume reduction was 73.6%, 80.1%, and 8.7% at six months after the intervention in the ethanol injection, RF ablation, and LT4 treatment groups, respectively (P &lt; 0.001). There was a significant relationship between the mean volume reduction and the follow-up period (one, three, and six months) (P &lt; 0.001).</div>
</article>
<article>
<div class="mb content text-indent">
<h4 class="font-main d-inline font-weight-bold">Conclusion:</h4>
The RF ablation therapy was found to be the optimal modality for the management of benign thyroid nodules, as it was associated with the greatest mean volume reduction. Conversely, the lowest mean volume reduction was observed in the LT4 treatment group during six months of follow-up.</div>
</article>
</div>]]></description>
<category><![CDATA[RF and Thyroid nodule]]></category>
<dc:creator>site-admin</dc:creator>
<pubDate>Fri, 29 Apr 2022 21:54:33 +0430</pubDate>
</item><item>
<title>Polycystic Ovary Syndrome</title>
<guid isPermaLink="true">https://drarefzadeh.com/19-Polycystic-Ovary-Syndrome.html</guid>
<link>https://drarefzadeh.com/19-Polycystic-Ovary-Syndrome.html</link>
<description><![CDATA[<p style="text-align: center;"><span style="font-size: 14pt;"><strong>How to start a contraceptive in Patients with PCOS.</strong></span></p>
<p style="text-align: center;">&nbsp;</p>
<p style="text-align: center;">&nbsp;</p>
<p style="text-align: center;">&nbsp;</p>]]></description>
<category><![CDATA[Polycystic Ovary Syndrome]]></category>
<dc:creator>site-admin</dc:creator>
<pubDate>Tue, 07 Jun 2016 00:25:43 +0430</pubDate>
</item><item>
<title>CV (Resume)</title>
<guid isPermaLink="true">https://drarefzadeh.com/18-CV-(Resume).html</guid>
<link>https://drarefzadeh.com/18-CV-(Resume).html</link>
<description><![CDATA[<p style="text-align: left;"><span style="font-size: 12pt;">Dr. Arefzadeh is Assistant Prof of Endocrinology and Metabolism.</span></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><span style="font-size: 12pt;">Dr. Arefzadeh graduated from Tehran University of Medical Sciences in the field of Internal Medicine in 2008.</span></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><span style="font-size: 12pt;">He graduated from&nbsp;Tehran University of Medical Sciences in the field of Endocrinology and Metabolism in 2012.</span></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><span style="font-size: 12pt;">He has many researchs about internal medicine and endocrinology fields.</span></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><span style="font-size: 12pt;">He is clinician and researcher and he works about diabetes mellitus, GDM, international education of diabetes and other endocrinology fields.</span></p>
<p><span style="font-size: 12pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 12pt;">He likes teaching students, interns, residents and fellowships. </span></p>
<p style="text-align: left;"><span style="font-size: 12pt;">Dr. Arefzadeh has IELTS Document and he can speak three languages: English, Danish and Persian.</span></p>
<p style="text-align: left;"><span style="font-size: 12pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 12pt;">Dr. Arefzadeh has educated Iranians around the world regarding on the importance of Diabetes Mellitus and other metabolic disorders and has helped to resolve problems in the Iranian community.</span></p>
<p><span style="font-size: 12pt;">&nbsp;</span></p>
<p style="text-align: left;"><span style="font-size: 12pt;">He is member of American Diabetes Association(ADA) and European Society of Endocrinology(ESE) and European Research Association(CORDIS).</span></p>
<p>&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>]]></description>
<category><![CDATA[CV]]></category>
<dc:creator>site-admin</dc:creator>
<pubDate>Sat, 07 Nov 2015 23:57:28 +0330</pubDate>
</item><item>
<title>FAQ from abroad</title>
<guid isPermaLink="true">https://drarefzadeh.com/17-Contact-patients-abroad.html</guid>
<link>https://drarefzadeh.com/17-Contact-patients-abroad.html</link>
<description><![CDATA[<p style="text-align: center;"><span style="font-size: 14pt;"><strong><span id="result_box" class="short_text" lang="en"><span class="hps">FAQ</span> <span class="hps">from <span style="font-size: 14pt;"><strong><span id="result_box" class="short_text" lang="en"><span class="hps">abroad</span></span></strong></span> <br /></span></span></strong></span></p>
<p style="text-align: center;"><span style="font-size: 14pt;"><strong><span id="result_box" class="short_text" lang="en"><span class="hps">&nbsp;</span></span></strong></span></p>
<p style="text-align: center;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><span style="font-size: 12pt;"><strong><span class="short_text" lang="en">Patients can contact me via my Email address: <a href="mailto:info@drarefzadeh.com">info@drarefzadeh.com</a> </span></strong></span></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>]]></description>
<category><![CDATA[ FAQ from abroad]]></category>
<dc:creator>site-admin</dc:creator>
<pubDate>Mon, 19 Oct 2015 11:32:41 +0330</pubDate>
</item><item>
<title>Stress and Diabetes</title>
<guid isPermaLink="true">https://drarefzadeh.com/16-Stress-and-Diabetes.html</guid>
<link>https://drarefzadeh.com/16-Stress-and-Diabetes.html</link>
<description><![CDATA[<p style="text-align: center;"><span style="font-size: 14pt;"><strong>Stresss and Diabetes</strong></span></p>
<p style="text-align: center;">&nbsp;</p>
<p style="text-align: center;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">Stress is the most important factor to predispose to diabetes.</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">Many diabetic patients have had a major stress before diabetes in my eperiences.</p>
<p style="text-align: left;">I have visited many diabetic patients who didn't&nbsp; have positive diabetic family history,however, they have developed diabetes and they had major stress before diabetes. &nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">Stress can increase blood sugar and it can lead to bad habits like overeating, which can make diabetes harder to manage.&nbsp;</p>
<p style="text-align: left;">Recerntly, some papers were published about this subject.</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">I strongly recommended to avoid stress and anxiety.</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">Dr. Alireza Arefzadeh.</p>]]></description>
<category><![CDATA[Stress and Diabetes]]></category>
<dc:creator>site-admin</dc:creator>
<pubDate>Sun, 18 Oct 2015 23:38:16 +0330</pubDate>
</item><item>
<title>News Media Technologies will create the revolution in education.</title>
<guid isPermaLink="true">https://drarefzadeh.com/15-News-Media-Technologies-will-create-the-revolution-in-education-.html</guid>
<link>https://drarefzadeh.com/15-News-Media-Technologies-will-create-the-revolution-in-education-.html</link>
<description><![CDATA[<p style="text-align: left;"><span style="font-size: 14pt;"><strong>News Media Technologies will create the revolution in education.</strong></span></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><span style="font-size: 8pt;"><strong>correspondent author:Alireza Arefzadeh</strong></span></p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><span style="font-size: 8pt;"><strong>Abstract<br />Introduction:<br />News media, including content and methods for presenting it,<br />unmistakably contribute to the informal education of our students outside the<br />classroom. In addition to considering new media (television, video games, Internet,<br />etc.) as educative agents and keeping their influence in mind, educational institutions<br />incorporate these media into programs of study as content&mdash;including analysis of their<br />importance in society, function, and the repercussions, they may have in our lives.<br />Discussion:<br />News multimedia technologies must fulfill many basic functions:<br />- represent and present both real and virtual worlds.<br />- facilitate teaching.<br />- enhance student learning.<br />- improve IQ, residential, distance memory, and life-long learning.<br />- accommodate students&rsquo; learning styles.<br />- Digital Text Writing.<br />- Digital knowledge<br />- Connect people to teachers and Students and experts.<br />- Online courses registry.<br />-More Velocity and better quality Services.<br />-Immediately self Examination and scored, providing quick feedback.<br />With the arrival of computers, written textual language was first to be digitized<br />because it required the least amount of resources. The new Digital text can be<br />modified more easily, it can be sent from one place to another, words or strings of<br />characters can be searched for and found instantly, etc.<br />Social networking sites allow students to explore their interests on a global scale and<br />discuss their interests with a wider range of people. This has huge implications for<br />self-learning, as information and resources are much more available than they were<br />previously. However, for students that aren&rsquo;t skilled at evaluating different content, it<br />can be hard for them to sort through various resources to find accurate and useful<br />information. Important Social networking sites are<br />Twitter,Wikipedia,Google,Yahoo, Facebook, and Youtube, Smartphones and<br />Iphone. Educational institutions will successfully wed academia and technology,<br />allowing students to learn in new and innovative ways. Technology has great potential<br />to help people learn, and businesses should capitalize on the advantages of technology<br />to create technologically advanced educational systems. They change to accommodate<br />students&rsquo; learning styles and significantly change education of the future. The Internet<br />allows people to search through digital knowledge and connect people to teachers and<br />experts. Textbooks can become interactive and can easily include updates and<br />corrections. Students will likely be able to get coursework from whichever university<br />they choose, and courses will likely be collaborative and public. These changes will<br />allow universities to teach anyone willing to learn, rather than only a select few in a<br />classroom. Technologies are already changing education, as online schools allow<br />students to earn degrees through only online courses Computer-Based Trainings are<br />self-paced activities on a computer that present content to a user. The trainings often<br />include assessments that can be immediately scored, providing quick feedback to the<br />users.<br />Conclusion: News Media Technologies provide revolution in education.</strong></span></p>]]></description>
<category><![CDATA[Medical Education]]></category>
<dc:creator>site-admin</dc:creator>
<pubDate>Wed, 07 Oct 2015 02:09:50 +0330</pubDate>
</item><item>
<title>Accuracy of three imaging modalities for evaluation of the posterior lens capsule in traumatic cataract</title>
<guid isPermaLink="true">https://drarefzadeh.com/14-Accuracy-of-three-imaging-modalities-for-evaluation-of-the-posterior-lens-capsule-in-traumatic-cataract.html</guid>
<link>https://drarefzadeh.com/14-Accuracy-of-three-imaging-modalities-for-evaluation-of-the-posterior-lens-capsule-in-traumatic-cataract.html</link>
<description><![CDATA[<h1 class="articleTitle" style="text-align: left;">Accuracy of 3 imaging modalities for evaluation of the posterior lens capsule in traumatic cataract</h1>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;">Click below link:</p>
<p style="text-align: left;">&nbsp;</p>
<p style="text-align: left;"><a href="http://www.google.com.ua/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=1&amp;ved=0CBsQFjAAahUKEwiisJqP6K7IAhVJnnIKHUWICAs&amp;url=http%3A%2F%2Fwww.jcrsjournal.org%2Farticle%2FS0886-3350(14)00446-5%2Fabstract&amp;usg=AFQjCNGmPU9iJcWcEZVZehLalFcNMtFyBA&amp;bvm=bv.104615367,bs.2,d.bGg&amp;cad=rja" target="_blank">Accuracy of three imaging modalities for evaluation of the posterior lens capsule in traumatic cataract</a></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<h1 style="text-align: left;">Accuracy of 3 imaging modalities for evaluation of the posterior lens capsule in traumatic cataract.</h1>
<div class="auths" style="text-align: left;"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Tabatabaei%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24836968">Tabatabaei A</a><sup>1</sup>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Hasanlou%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24836968">Hasanlou N</a><sup>2</sup>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Kheirkhah%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24836968">Kheirkhah A</a><sup>1</sup>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Mansouri%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24836968">Mansouri M</a><sup>1</sup>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Faghihi%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24836968">Faghihi H</a><sup>1</sup>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Jafari%20H%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24836968">Jafari H</a><sup>1</sup>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Arefzadeh%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24836968">Arefzadeh A</a><sup>1</sup>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Moghimi%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=24836968">Moghimi S</a><sup>1</sup></div>
<div class="auths" style="text-align: left;"></div>
<div class="auths" style="text-align: left;">
<h3>Abstract</h3>
<h4>PURPOSE:</h4>
<p>To compare the accuracy of 3 imaging modalities for preoperative evaluation of the posterior lens capsule in traumatic cataract.</p>
<h4>SETTING:</h4>
<p>Farabi Eye Hospital, Tehran, Iran.</p>
<h4>DESIGN:</h4>
<p>Case series.</p>
<h4>METHODS:</h4>
<p>The study comprised eyes with traumatic cataract opaque enough to prevent visualization of the posterior lens capsule on slitlamp examination. To detect posterior lens capsule rupture before surgery, imaging was performed with 20 MHz echography (Eye Cubed), anterior segment optical coherence tomography (AS-OCT) (Visante model 1000), and Scheimpflug imaging (Pentacam). All patients subsequently had cataract extraction, and the intraoperative findings of the posterior lens capsule were compared with the preoperative findings of the imaging modalities.</p>
<h4>RESULTS:</h4>
<p>The study enrolled 21 eyes of 21 patients (20 men, 1 woman) with a mean age of 31.5 years &plusmn; 1.45 (SD). The nature of trauma was blunt (5 eyes) or sharp (16 eyes). To detect posterior lens capsule rupture, the sensitivity and specificity were, respectively, 80% and 86% for 20 MHz echography, 71% and 77% for AS-OCT, and 62% and 57% for Scheimpflug imaging (95% confidence intervals: sensitivity, 30.00-90.32; specificity, 54.81-92.95). Insufficient resolution for posterior lens capsule evaluation occurred in 33.3% cases for AS-OCT and 57.1% cases for Scheimpflug imaging. The accuracy of 20 MHz echography, AS-OCT, and Scheimpflug imaging was 76.1%, 61.9%, and 42.9%, respectively.</p>
<h4>CONCLUSION:</h4>
<p>In the evaluation of the posterior lens capsule in eyes with traumatic cataract, 20 MHz echography had higher accuracy than AS-OCT and Scheimpflug imaging.</p>
</div>]]></description>
<category><![CDATA[Others]]></category>
<dc:creator>site-admin</dc:creator>
<pubDate>Wed, 07 Oct 2015 02:05:22 +0330</pubDate>
</item></channel></rss>